These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6082405)

  • 1. [Current significance of the local-regional use of radioisotopes in the therapy of malignant tumors (in association with surgery). Introduction to the Symposium].
    Turano L
    Minerva Med; 1967 Dec; 58(99):4478-9. PubMed ID: 6082405
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current status of the boron neutron capture therapy of tumors].
    Spryshkova RA; Iagubov AS; Grigor'eva EIu; Koldaeva EIu
    Vopr Onkol; 1995; 41(2):106-7. PubMed ID: 7483399
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical aspects of local and regional tumor therapy with 188Re-RC-160.
    Bender H; Zamora PO; Rhodes BA; Guhlke S; Biersack HJ
    Anticancer Res; 1997; 17(3B):1705-12. PubMed ID: 9179223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irradiation of malignant tumors in the field of otorhinolaryngology using radio-controlled iridium-192 contact irradiation].
    Feine U; Koburg E
    Strahlentherapie Sonderb; 1969; 68():178-82. PubMed ID: 5768033
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium: general approaches in the management of neoplasms. Findings and general concepts on the radiotherapeutic management of cancer].
    Noriega Limón J
    Cir Cir; 1969; 37(3):196-206. PubMed ID: 5350884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Surgical considerations on the regional use of radioisotopes].
    Malan E
    Minerva Med; 1967 Dec; 58(99):4482-3. PubMed ID: 6082407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on thedose absorbed by the operators in loco-regional radiotherapy with beta-emitting radioisotopes].
    Sannazzari GL; Cavalli A; Catolla Cavalcanti R; Pietroiusti M
    Minerva Med; 1967 Dec; 58(99):4490-2. PubMed ID: 6082411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principal methods and current technology of radiation therapy in the combined treatment of patients with malignant tumors].
    Dar'ialova SL; Boĭko AV; Chernichenko AV
    Vopr Onkol; 1997; 43(5):496-9. PubMed ID: 9432789
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosimetry for cystic-type tumors.
    McGuire EL; Boyd CM; Balachandran S; Eason CS
    J Nucl Med; 1986 Sep; 27(9):1501-3. PubMed ID: 3746449
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in radionuclide therapy, 1983.
    Beierwaltes WH
    J Nucl Med Allied Sci; 1983; 27(3):249-52. PubMed ID: 6663358
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are radiation oncologists serious about systemic radiation therapy and if not, should we be?
    Wallner PE; Coleman CN; Brechbiel M; Milenic D; Tripuraneni P
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):1-2. PubMed ID: 15337532
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of therapy of solid tumors: brain tumor therapy.
    Zalutsky MR
    J Nucl Med; 2005 Jan; 46 Suppl 1():151S-6S. PubMed ID: 15653663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current possibilities of scintigraphic localization of pancreatic tumors as a prerequisite for internal radioisotope therapy].
    Turano L; Centi Colella A; Pigorini F
    Minerva Med; 1967 Dec; 58(99):4494-5. PubMed ID: 6082414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Internal radioisotope therapy: history, results and presumable future possibilities].
    Muller JH
    Minerva Med; 1967 Dec; 58(99):4481-2. PubMed ID: 6082406
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential and pitfalls of therapy with alpha-particles.
    Welch MJ
    J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron.
    Thisgaard H; Jensen M
    Appl Radiat Isot; 2009 Jan; 67(1):34-8. PubMed ID: 18990581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic perspective on molecular targeted radionuclide therapy.
    Larson SM; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():1S-3S. PubMed ID: 15653645
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
    Reilly RM
    J Nucl Med; 2006 Feb; 47(2):196-9. PubMed ID: 16455623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.